Does RAVULIZUMAB-CWVZ Cause Covid-19? 220 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 220 reports of Covid-19 have been filed in association with RAVULIZUMAB-CWVZ. This represents 2.2% of all adverse event reports for RAVULIZUMAB-CWVZ.
220
Reports of Covid-19 with RAVULIZUMAB-CWVZ
2.2%
of all RAVULIZUMAB-CWVZ reports
2
Deaths
58
Hospitalizations
How Dangerous Is Covid-19 From RAVULIZUMAB-CWVZ?
Of the 220 reports, 2 (0.9%) resulted in death, 58 (26.4%) required hospitalization, and 1 (0.5%) were considered life-threatening.
Is Covid-19 Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RAVULIZUMAB-CWVZ. However, 220 reports have been filed with the FAERS database.
What Other Side Effects Does RAVULIZUMAB-CWVZ Cause?
Fatigue (1,472)
Asthenia (727)
Headache (639)
Drug ineffective (570)
Off label use (451)
Muscular weakness (422)
Dyspnoea (414)
Malaise (353)
Haemoglobin decreased (346)
Myasthenia gravis (338)
What Other Drugs Cause Covid-19?
NIRMATRELVIR\RITONAVIR (22,066)
OCRELIZUMAB (11,454)
ADALIMUMAB (9,138)
DUPILUMAB (6,986)
RITUXIMAB (6,301)
LENALIDOMIDE (6,223)
TOFACITINIB (4,926)
SECUKINUMAB (3,871)
INFLIXIMAB (3,698)
TACROLIMUS (3,201)
Which RAVULIZUMAB-CWVZ Alternatives Have Lower Covid-19 Risk?
RAVULIZUMAB-CWVZ vs REBAMIPIDE
RAVULIZUMAB-CWVZ vs REBETOL
RAVULIZUMAB-CWVZ vs REBIF
RAVULIZUMAB-CWVZ vs REBOXETINE
RAVULIZUMAB-CWVZ vs RECLAST